HIV-1 mutates to evade IFITM1 restriction

Virology

Volumn 454-455, Issue 1, 2014, Pages 11-24

  Ding, Shilei ^a,b   Pan, Qinghua ^a   Liu, Shan Lu ^c   Liang, Chen ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c University of Missouri   (United States)

Author keywords

Cell to cell transmission; Escape mutations; HIV 1; IFITM1

Indexed keywords

CD4 ANTIGEN; GAG PROTEIN; INTERFERON; INTERFERON INDUCED TRANSMEMBRANE PROTEIN; MEMBRANE PROTEIN; UNCLASSIFIED DRUG; VIRUS ENVELOPE PROTEIN; VPU PROTEIN;

AMINO ACID SEQUENCE; ARTICLE; BINDING SITE; DOWN REGULATION; GENE MAPPING; GENE MUTATION; GENE SEQUENCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; STOP CODON; VIRUS GENOME; VIRUS MUTATION; VIRUS REPLICATION; VIRUS TRANSMISSION; WESTERN BLOTTING;

CELL-TO-CELL TRANSMISSION; ESCAPE MUTATIONS; HIV-1; IFITM1;

ANTIGENS, DIFFERENTIATION; CELL LINE; DNA MUTATIONAL ANALYSIS; ENV GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; HIV-1; HUMAN IMMUNODEFICIENCY VIRUS PROTEINS; HUMANS; IMMUNE EVASION; MUTATION; SEQUENCE ANALYSIS, DNA; SERIAL PASSAGE; VIRAL REGULATORY AND ACCESSORY PROTEINS;

EID: 84896515906     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2014.01.020     Document Type: Article

References (57)

1. Alber D., Staeheli P. Partial inhibition of vesicular stomatitis virus by the interferon-induced human 9-27 protein. J. Interferon Cytokine Res. 1996, 16(5):375-380.
2. Amini-Bavil-Olyaee S., Choi Y.J., Lee J.H., Shi M., Huang I.C., Farzan M., Jung J.U. The antiviral effector IFITM3 disrupts intracellular cholesterol homeostasis to block viral entry. Cell Host Microbe 2013, 13(4):452-464.
3. Anafu A.A., Bowen C.H., Chin C.R., Brass A.L., Holm G.H. Interferon inducible transmembrane protein 3 (IFITM3) restricts reovirus cell entry. J. Biol. Chem. 2013, 288(24):17261-17271.
4. Andreu P., Colnot S., Godard C., Laurent-Puig P., Lamarque D., Kahn A., Perret C., Romagnolo B. Identification of the IFITM family as a new molecular marker in human colorectal tumors. Cancer Res. 2006, 66(4):1949-1955.
5. Bailey C.C., Huang I.C., Kam C., Farzan M. IFITM3 limits the severity of acute influenza in mice. PLoS Pathog. 2012, 8(9):e1002909.
6. Bailey C.C., Kondur H.R., Huang I.C., Farzan M. Interferon-induced transmembrane protein 3 is a Type II transmembrane protein. J. Biol. Chem. 2013.
7. Bhanja Chowdhury J., Shrivastava S., Steele R., Di Bisceglie A.M., Ray R., Ray R.B. Hepatitis C virus infection modulates expression of interferon stimulatory gene IFITM1 by upregulating miR-130A. J. Virol. 2012, 86(18):10221-10225.
8. Brass A.L., Huang I.C., Benita Y., John S.P., Krishnan M.N., Feeley E.M., Ryan B.J., Weyer J.L., van der Weyden L., Fikrig E., Adams D.J., Xavier R.J., Farzan M., Elledge S.J. The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus. Cell 2009, 139(7):1243-1254.
9. Brem R., Oraszlan-Szovik K., Foser S., Bohrmann B., Certa U. Inhibition of proliferation by 1-8U in interferon-alpha-responsive and non-responsive cell lines. Cell. Mol. Life Sci. 2003, 60(6):1235-1248.
10. Cavrois M., De Noronha C., Greene W.C. A sensitive and specific enzyme-based assay detecting HIV-1 virion fusion in primary T lymphocytes. Nat. Biotechnol. 2002, 20(11):1151-1154.
11. Chutiwitoonchai N., Hiyoshi M., Hiyoshi-Yoshidomi Y., Hashimoto M., Tokunaga K., Suzu S. Characteristics of IFITM, the newly identified IFN-inducible anti-HIV-1 family proteins. Microbes Infect. 2013, 15(4):280-290.
12. Deblandre G.A., Marinx O.P., Evans S.S., Majjaj S., Leo O., Caput D., Huez G.A., Wathelet M.G. Expression cloning of an interferon-inducible 17-kDa membrane protein implicated in the control of cell growth. J. Biol. Chem. 1995, 270(40):23860-23866.
13. Diamond M.S., Farzan M. The broad-spectrum antiviral functions of IFIT and IFITM proteins. Nat. Rev. Immunol. 2013, 13(1):46-57.
14. Dube M., Bego M.G., Paquay C., Cohen E.A. Modulation of HIV-1-host interaction: role of the Vpu accessory protein. Retrovirology 2010, 7:114.
15. Evans S.S., Collea R.P., Leasure J.A., Lee D.B. IFN-alpha induces homotypic adhesion and Leu-13 expression in human B lymphoid cells. J. Immunol. 1993, 150(3):736-747.
16. Evans S.S., Lee D.B., Han T., Tomasi T.B., Evans R.L. Monoclonal antibody to the interferon-inducible protein Leu-13 triggers aggregation and inhibits proliferation of leukemic B cells. Blood 1990, 76(12):2583-2593.
17. Everitt A.R., Clare S., Pertel T., John S.P., Wash R.S., Smith S.E., Chin C.R., Feeley E.M., Sims J.S., Adams D.J., Wise H.M., Kane L., Goulding D., Digard P., Anttila V., Baillie J.K., Walsh T.S., Hume D.A., Palotie A., Xue Y., Colonna V., Tyler-Smith C., Dunning J., Gordon S.B., Smyth R.L., Openshaw P.J., Dougan G., Brass A.L., Kellam P. IFITM3 restricts the morbidity and mortality associated with influenza. Nature 2012, 484(7395):519-523.
18. Feeley E.M., Sims J.S., John S.P., Chin C.R., Pertel T., Chen L.M., Gaiha G.D., Ryan B.J., Donis R.O., Elledge S.J., Brass A.L. IFITM3 inhibits influenza A virus infection by preventing cytosolic entry. PLoS Pathog. 2011, 7(10):e1002337.
19. Gummuluru S., Kinsey C.M., Emerman M. An in vitro rapid-turnover assay for human immunodeficiency virus type 1 replication selects for cell-to-cell spread of virus. J. Virol. 2000, 74(23):10882-10891.
20. Hanagata N., Li X., Morita H., Takemura T., Li J., Minowa T. Characterization of the osteoblast-specific transmembrane protein IFITM5 and analysis of IFITM5-deficient mice. J. Bone Miner. Metab. 2010, 29(3):279-290.
21. Hickford D.E., Frankenberg S.R., Shaw G., Renfree M.B. Evolution of vertebrate interferon inducible transmembrane proteins. BMC Genomics 2012, 13(1):155.
22. Hrecka K., Hao C., Gierszewska M., Swanson S.K., Kesik-Brodacka M., Srivastava S., Florens L., Washburn M.P., Skowronski J. Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein. Nature 2011, 474(7353):658-661.
23. Huang I.C., Bailey C.C., Weyer J.L., Radoshitzky S.R., Becker M.M., Chiang J.J., Brass A.L., Ahmed A.A., Chi X., Dong L., Longobardi L.E., Boltz D., Kuhn J.H., Elledge S.J., Bavari S., Denison M.R., Choe H., Farzan M. Distinct patterns of IFITM-mediated restriction of filoviruses, SARS coronavirus, and influenza A virus. PLoS Pathog. 2011, 7(1):e1001258.
24. Jia R., Pan Q., Ding S., Rong L., Liu S.L., Geng Y., Qiao W., Liang C. The N-terminal region of IFITM3 modulates its antiviral activity by regulating IFITM3 cellular localization. J. Virol. 2012, 86(24):13697-13707.
25. Jiang D., Weidner J.M., Qing M., Pan X.B., Guo H., Xu C., Zhang X., Birk A., Chang J., Shi P.Y., Block T.M., Guo J. Identification of five interferon-induced cellular proteins that inhibit west Nile virus and dengue virus infections. J. Virol. 2010, 84(16):8332-8341.
26. Jolly C., Booth N.J., Neil S.J. Cell-cell spread of human immunodeficiency virus type 1 overcomes tetherin/BST-2-mediated restriction in T cells. J. Virol. 2010, 84(23):12185-12199.
27. Laguette N., Sobhian B., Casartelli N., Ringeard M., Chable-Bessia C., Segeral E., Yatim A., Emiliani S., Schwartz O., Benkirane M. SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx. Nature 2011, 474(7353):654-657.
28. Lewin A.R., Reid L.E., McMahon M., Stark G.R., Kerr I.M. Molecular analysis of a human interferon-inducible gene family. Eur. J. Biochem. 1991, 199(2):417-423.
29. Li K., Markosyan R.M., Zheng Y.M., Golfetto O., Bungart B., Li M., Ding S., He Y., Liang C., Lee J.C., Gratton E., Cohen F.S., Liu S.L. IFITM proteins restrict viral membrane hemifusion. PLoS Pathog. 2013, 9(1):e1003124.
30. Li M., Kao E., Gao X., Sandig H., Limmer K., Pavon-Eternod M., Jones T.E., Landry S., Pan T., Weitzman M.D., David M. Codon-usage-based inhibition of HIV protein synthesis by human schlafen 11. Nature 2012, 491(7422):125-128.
31. Lu J., Pan Q., Rong L., He W., Liu S.L., Liang C. The IFITM proteins inhibit HIV-1 infection. J. Virol. 2011, 85(5):2126-2137.
32. Luttge B.G., Panchal P., Puri V., Checkley M.A., Freed E.O. Mutations in the feline immunodeficiency virus envelope glycoprotein confer resistance to a dominant-negative fragment of Tsg101 by enhancing infectivity and cell-to-cell virus transmission. Biochim. Biophys. Acta. 2013.
33. Malim M.H., Bieniasz P.D. HIV restriction factors and mechanisms of evasion. Cold Spring Harb. Perspect. Med. 2012, 2(5):a006940.
34. Moffatt P., Gaumond M.H., Salois P., Sellin K., Bessette M.C., Godin E., de Oliveira P.T., Atkins G.J., Nanci A., Thomas G. Bril: a novel bone-specific modulator of mineralization. J. Bone Miner. Res. 2008, 23(9):1497-1508.
35. Mudhasani R., Tran J.P., Retterer C., Radoshitzky S.R., Kota K.P., Altamura L.A., Smith J.M., Packard B.Z., Kuhn J.H., Costantino J., Garrison A.R., Schmaljohn C.S., Huang I.C., Farzan M., Bavari S. IFITM-2 and IFITM-3 but Not IFITM-1 restrict Rift Valley Fever Virus. J. Virol. 2013, 87(15):8451-8464.
36. Neil S.J., Zang T., Bieniasz P.D. Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu. Nature 2008, 451(7177):425-430.
37. Perreira, J.M., Chin, C.R., Feeley, E.M., and Brass, A.L. (2013). IFITMs restrict the replication of multiple pathogenic viruses. J. Mol. Biol.
38. Raychoudhuri A., Shrivastava S., Steele R., Kim H., Ray R., Ray R.B. ISG56 and IFITM1 proteins inhibit hepatitis C virus replication. J. Virol. 2011, 85(24):12881-12889.
39. Rong L., Zhang J., Lu J., Pan Q., Lorgeoux R.P., Aloysius C., Guo F., Liu S.L., Wainberg M.A., Liang C. The transmembrane domain of BST-2 determines its sensitivity to down-modulation by human immunodeficiency virus type 1 Vpu. J. Virol. 2009, 83(15):7536-7546.
40. Sadler A.J., Williams B.R. Interferon-inducible antiviral effectors. Nat. Rev. Immunol. 2008, 8(7):559-568.
41. Sattentau Q. Avoiding the void: cell-to-cell spread of human viruses. Nat. Rev. Microbiol. 2008, 6(11):815-826.
42. Schoggins J.W., Wilson S.J., Panis M., Murphy M.Y., Jones C.T., Bieniasz P., Rice C.M. A diverse range of gene products are effectors of the type I interferon antiviral response. Nature 2011, 472(7344):481-485.
43. Seo G.S., Lee J.K., Yu J.I., Yun K.J., Chae S.C., Choi S.C. Identification of the polymorphisms in IFITM3 gene and their association in a Korean population with ulcerative colitis. Exp. Mol. Med. 2010, 42(2):99-104.
44. Siegrist F., Ebeling M., Certa U. The small interferon-induced transmembrane genes and proteins. J. Interferon Cytokine Res. 2011, 31(1):183-197.
45. Stremlau M., Owens C.M., Perron M.J., Kiessling M., Autissier P., Sodroski J. The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys. Nature 2004, 427(6977):848-853.
46. Wakim L.M., Gupta N., Mintern J.D., Villadangos J.A. Enhanced survival of lung tissue-resident memory CD8(+) T cells during infection with influenza virus due to selective expression of IFITM3. Nat. Immunol. 2013, 14(3):238-245.
47. Wei X., Decker J.M., Liu H., Zhang Z., Arani R.B., Kilby J.M., Saag M.S., Wu X., Shaw G.M., Kappes J.C. Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy. Antimicrob. Agents Chemother. 2002, 46(6):1896-1905.
48. Weidner J.M., Jiang D., Pan X.B., Chang J., Block T.M., Guo J.T. Interferon-induced cell membrane proteins, IFITM3 and tetherin, inhibit vesicular stomatitis virus infection via distinct mechanisms. J. Virol. 2010, 84(24):12646-12657.
49. Wu X., Zhou T., Zhu J., Zhang B., Georgiev I., Wang C., Chen X., Longo N.S., Louder M., McKee K., O'Dell S., Perfetto S., Schmidt S.D., Shi W., Wu L., Yang Y., Yang Z.Y., Yang Z., Zhang Z., Bonsignori M., Crump J.A., Kapiga S.H., Sam N.E., Haynes B.F., Simek M., Burton D.R., Koff W.C., Doria-Rose N.A., Connors M., Mullikin J.C., Nabel G.J., Roederer M., Shapiro L., Kwong P.D., Mascola J.R. Focused evolution of HIV-1 neutralizing antibodies revealed by structures and deep sequencing. Science 2010, 333(6049):1593-1602.
50. Wu Y., Beddall M.H., Marsh J.W. Rev-dependent indicator T cell line. Curr. HIV Res. 2007, 5(4):394-402.
51. Yamashita T., Hashimoto S., Kaneko S., Nagai S., Toyoda N., Suzuki T., Kobayashi K., Matsushima K. Comprehensive gene expression profile of a normal human liver. Biochem Biophys Res Commun 2000, 269(1):110-116.
52. Yang G., Xu Y., Chen X., Hu G. IFITM1 plays an essential role in the antiproliferative action of interferon-gamma. Oncogene 2007, 26(4):594-603.
53. Yount J.S., Karssemeijer R.A., Hang H.C. S-palmitoylation and ubiquitination differentially regulate interferon-induced transmembrane protein 3 (IFITM3)-mediated resistance to influenza virus. J. Biol. Chem. 2012, 287(23):19631-19641.
54. Yount J.S., Moltedo B., Yang Y.Y., Charron G., Moran T.M., Lopez C.B., Hang H.C. Palmitoylome profiling reveals S-palmitoylation-dependent antiviral activity of IFITM3. Nat. Chem. Biol. 2010, 6(8):610-614.
55. Zhang Y. I-TASSER server for protein 3D structure prediction. BMC Bioinforma. 2008, 9:40.
56. Zhou T., Georgiev I., Wu X., Yang Z.Y., Dai K., Finzi A., Kwon Y.D., Scheid J.F., Shi W., Xu L., Yang Y., Zhu J., Nussenzweig M.C., Sodroski J., Shapiro L., Nabel G.J., Mascola J.R., Kwong P.D. Structural basis for broad and potent neutralization of HIV-1 by antibody VRC01. Science 2010, 329(5993):811-817.
57. Zucchi I., Prinetti A., Scotti M., Valsecchi V., Valaperta R., Mento E., Reinbold R., Vezzoni P., Sonnino S., Albertini A., Dulbecco R. Association of rat8 with Fyn protein kinase via lipid rafts is required for rat mammary cell differentiation in vitro. Proc. Natl. Acad. Sci. USA 2004, 101(7):1880-1885.